CD4+ T-cell subsets in intestinal inflammation
暂无分享,去创建一个
[1] Jay K Kolls,et al. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. , 2013, Annual review of pathology.
[2] F. Powrie,et al. Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation , 2012, Immunity.
[3] Andrew J. Oler,et al. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. , 2012, Immunity.
[4] Richard Bonneau,et al. A Validated Regulatory Network for Th17 Cell Specification , 2012, Cell.
[5] Daniel J. Kuster,et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo , 2012, The Journal of experimental medicine.
[6] J. Weiss,et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells , 2012, The Journal of experimental medicine.
[7] D. Roos,et al. The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. , 2012, Immunity.
[8] D. Littman,et al. Small molecule inhibitors of RORγt: Targeting Th17 cells and other applications , 2012, European journal of immunology.
[9] Burkhard Becher,et al. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells , 2012, The Journal of experimental medicine.
[10] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[11] B. Jabri,et al. A specific role for TLR1 in protective TH17 immunity during mucosal infection , 2012, The Journal of experimental medicine.
[12] Marc Vandemeulebroecke,et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.
[13] Meena Subramanyam,et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. , 2012, The New England journal of medicine.
[14] D. Jarrossay,et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β , 2012, Nature.
[15] A. Rudensky,et al. Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.
[16] G. Núñez,et al. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine , 2012, The Journal of experimental medicine.
[17] A. Rudensky,et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation , 2012, Nature.
[18] Sharon K. Ahluwalia,et al. Peripheral Education of the Immune System by Colonic Commensal Microbiota , 2012 .
[19] Wei Hu,et al. Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. , 2011, Immunity.
[20] C. Klein,et al. IL‐10 and IL‐10 receptor defects in humans , 2011, Annals of the New York Academy of Sciences.
[21] A. Rizzo,et al. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer , 2011, The Journal of experimental medicine.
[22] Y. Wan,et al. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. , 2011, Immunity.
[23] C. Huttenhower,et al. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. , 2011, Cell host & microbe.
[24] Vineet K. Sharma,et al. Complete genome sequences of rat and mouse segmented filamentous bacteria, a potent inducer of th17 cell differentiation. , 2011, Cell host & microbe.
[25] Y. Belkaid,et al. The role of retinoic acid in tolerance and immunity. , 2011, Immunity.
[26] T. Chatila,et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. , 2011, Immunity.
[27] J. Bluestone,et al. Control of TH17 cells occurs in the Small Intestine , 2011, Nature.
[28] A. Hoischen,et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.
[29] Hilde Cheroutre,et al. The light and dark sides of intestinal intraepithelial lymphocytes , 2011, Nature Reviews Immunology.
[30] Fiona Powrie,et al. Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.
[31] D. Vignali,et al. Cutting Edge: Human Regulatory T Cells Require IL-35 To Mediate Suppression and Infectious Tolerance , 2011, The Journal of Immunology.
[32] F. Safavi,et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.
[33] C. Elson,et al. Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production , 2011, The Journal of Immunology.
[34] L. Lefrançois,et al. Regional and mucosal memory T cells , 2011, Nature Immunology.
[35] B. Becher,et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.
[36] S. Hapfelmeier,et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. , 2011, Immunity.
[37] Y. Wan,et al. Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology , 2011, The Journal of experimental medicine.
[38] R. Caspi,et al. Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses. , 2011 .
[39] O. Lantz,et al. Mucosal-associated invariant T cells: unconventional development and function. , 2011, Trends in immunology.
[40] J. Mora,et al. Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases. , 2011, Gastroenterology.
[41] D. Artis,et al. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.
[42] Dan R. Littman,et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity , 2011, Nature.
[43] A. Rudensky,et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.
[44] Francis J. Huber,et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.
[45] Richard A Flavell,et al. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. , 2011, Immunity.
[46] C. Elson,et al. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. , 2011, Immunity.
[47] Y. Belkaid,et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. , 2011, Immunity.
[48] T. Waldmann,et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens , 2011, Nature.
[49] Werner Müller,et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. , 2011, Immunity.
[50] P. Bousso,et al. Restricted Microbiota and Absence of Cognate TCR Antigen Leads to an Unbalanced Generation of Th17 Cells , 2011, The Journal of Immunology.
[51] D. Artis,et al. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. , 2011, Immunity.
[52] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[53] L. Diehl,et al. IL-27 promotes T cell–dependent colitis through multiple mechanisms , 2011, The Journal of experimental medicine.
[54] R. Panush. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2011 .
[55] 박주홍,et al. The Toll-Like Receptor 2 pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011 .
[56] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[57] M. J. Broadhurst,et al. IL-22+ CD4+ T Cells Are Associated with Therapeutic Trichuris trichiura Infection in an Ulcerative Colitis Patient , 2010, Science Translational Medicine.
[58] Scott A. Brown,et al. IL-35-mediated induction of a potent regulatory T cell population , 2010, Nature Immunology.
[59] Todd Davidson,et al. Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.
[60] L. Wheeler,et al. Effect of &agr;4&bgr;7 blockade on intestinal lymphocyte subsets and lymphoid tissue development , 2010, Inflammatory bowel diseases.
[61] M. Grisham,et al. Gut‐associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation , 2010, Annals of the New York Academy of Sciences.
[62] F. Powrie,et al. Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.
[63] T. Macdonald,et al. Interferon‐gamma‐expressing cells are a major source of interleukin‐21 in inflammatory bowel diseases , 2010, Inflammatory bowel diseases.
[64] S. Mazmanian,et al. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.
[65] D. Artis,et al. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A , 2010, The Journal of experimental medicine.
[66] Steffen Jung,et al. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria , 2010, Nature Reviews Immunology.
[67] F. Powrie,et al. OX40 is required for regulatory T cell–mediated control of colitis , 2010, The Journal of experimental medicine.
[68] Y. Belkaid,et al. Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.
[69] W. Paul,et al. Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.
[70] Dan R. Littman,et al. Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.
[71] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[72] A. Macpherson,et al. Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.
[73] A. Fischer,et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2010, The Journal of experimental medicine.
[74] A. Rudensky,et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate , 2010, Nature.
[75] P. Rutgeerts,et al. Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study , 2010, Inflammatory bowel diseases.
[76] G. Weinstock,et al. Enteric defensins are essential regulators of intestinal microbial ecology , 2009, Nature Immunology.
[77] Johan Van Limbergen,et al. Common variants at five new loci associated with early-onset inflammatory bowel disease , 2009, Nature Genetics.
[78] A. Rudensky,et al. CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner , 2009, Science.
[79] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[80] Annaïg Lan,et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. , 2009, Immunity.
[81] F. Powrie,et al. Regulatory T cells reinforce intestinal homeostasis. , 2009, Immunity.
[82] C. Weaver,et al. Intestinal effector T cells in health and disease. , 2009, Immunity.
[83] G. Eberl,et al. The development of intestinal lymphoid tissues at the interface of self and microbiota , 2009, Mucosal Immunology.
[84] J. Bluestone,et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.
[85] C. Hunter,et al. IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis1 , 2009, The Journal of Immunology.
[86] S. Brand. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease , 2009, Gut.
[87] L. Bradley. Faculty Opinions recommendation of The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. , 2009 .
[88] N. Cerf-Bensussan,et al. Innate T cell responses in human gut. , 2009, Seminars in immunology.
[89] Richard A Flavell,et al. A protective function for interleukin 17A in T cell–mediated intestinal inflammation , 2009, Nature Immunology.
[90] M. Neurath,et al. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. , 2009, Gastroenterology.
[91] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[92] F. Powrie,et al. Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.
[93] T. Chatila,et al. A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis1 , 2009, The Journal of Immunology.
[94] B. Pulendran,et al. TLR2 dependent induction of vitamin A metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits TH-17 mediated autoimmunity , 2009, Nature Medicine.
[95] A. Keegan. Faculty Opinions recommendation of Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. , 2009 .
[96] R. D. Hatton,et al. Contrasting roles for all-trans retinoic acid in TGF-β–mediated induction of Foxp3 and Il10 genes in developing regulatory T cells , 2009, The Journal of experimental medicine.
[97] T. Mcclanahan,et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.
[98] C. Elson,et al. Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.
[99] C. Sasakawa,et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.
[100] B. Becher,et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. , 2009, Gastroenterology.
[101] C. Hsieh,et al. Antigen-specific peripheral shaping of the natural regulatory T cell population , 2008, The Journal of experimental medicine.
[102] A. Murphy,et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.
[103] T. Okanoue,et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. , 2008, Biochemical and biophysical research communications.
[104] C. Dong. Regulation and pro‐inflammatory function of interleukin‐17 family cytokines , 2008, Immunological reviews.
[105] H. Yoshida,et al. Regulation of immune responses by interleukin‐27 , 2008, Immunological reviews.
[106] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[107] E. Kremmer,et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo , 2008, The Journal of experimental medicine.
[108] J. Berzofsky,et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. , 2008, Immunity.
[109] R Balfour Sartor,et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.
[110] Masahiro Yamamoto,et al. ATP drives lamina propria TH17 cell differentiation , 2008, Nature.
[111] R. Kastelein,et al. Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine , 2008, The Journal of experimental medicine.
[112] L. Cosmi,et al. Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.
[113] S. Tangye,et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.
[114] D. Riethmacher,et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells , 2008, The Journal of experimental medicine.
[115] F. Powrie,et al. Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.
[116] C. Hunter,et al. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. , 2008, International immunology.
[117] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[118] S. Mazmanian,et al. A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.
[119] R. Broaddus,et al. Regulation of inflammatory responses by IL-17F , 2008, The Journal of experimental medicine.
[120] Yuelei Shen,et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.
[121] F. Powrie,et al. Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis , 2008, Immunity.
[122] A. Rizzo,et al. Regulation of gut inflammation and th17 cell response by interleukin-21. , 2008, Gastroenterology.
[123] S. Brand,et al. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL‐22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status , 2008, Inflammatory bowel diseases.
[124] J. Mora,et al. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. , 2008, Inflammatory bowel diseases.
[125] R. Xavier,et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.
[126] M. Huber,et al. IL-27 inhibits the development of regulatory T cells via STAT3. , 2008, International immunology.
[127] Chen Dong,et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.
[128] J. Berzofsky. Faculty Opinions recommendation of TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. , 2007 .
[129] Yue Zhang,et al. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner. , 2007, International immunology.
[130] T. Mcclanahan,et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.
[131] Christophe Benoist,et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.
[132] K. Boyd,et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.
[133] I. McInnes,et al. IL‐35 is a novel cytokine with therapeutic effects against collagen‐induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells , 2007, European journal of immunology.
[134] Hua Yu,et al. Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1 , 2007, The Journal of Immunology.
[135] D. Levy,et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.
[136] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[137] A. Rudensky,et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10 , 2007, Nature Immunology.
[138] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[139] W. Paul,et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis , 2007, European journal of immunology.
[140] T. Mcclanahan,et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. , 2007, Gastroenterology.
[141] Y. Wan,et al. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. , 2007, Immunity.
[142] J. Coombes,et al. Control of intestinal homeostasis by regulatory T cells and dendritic cells. , 2007, Seminars in immunology.
[143] C. Eun. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. , 2007 .
[144] Judy H. Cho,et al. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.
[145] D. Hommes,et al. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn’s disease , 2006, Gut.
[146] F. Powrie,et al. Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 , 2006, The Journal of Immunology.
[147] A. Sher,et al. IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.
[148] F. Powrie,et al. Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.
[149] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[150] M. Neurath,et al. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications , 2006, Gut.
[151] R. Flavell,et al. Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms , 2006 .
[152] A. Rudensky,et al. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. , 2006, Immunity.
[153] L. Lefrançois,et al. Evidence that a significant number of naive T cells enter non‐lymphoid organs as part of a normal migratory pathway , 2006, European journal of immunology.
[154] T. Mcclanahan,et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.
[155] F. Powrie,et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.
[156] K. Herrmann,et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[157] L. Lefrançois,et al. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. , 2006, Annual review of immunology.
[158] R. Flavell,et al. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. , 2006, Immunity.
[159] D. Littman,et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.
[160] R. Alon,et al. Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.
[161] S. Mazmanian,et al. An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.
[162] R. Coffman,et al. T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.
[163] T. Watts,et al. TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.
[164] A. Macpherson,et al. Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.
[165] P. Mannon,et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. , 2004, The Journal of clinical investigation.
[166] A. Andoh,et al. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. , 2004, Clinical immunology.
[167] F. D. de Sauvage,et al. IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[168] D. Hommes,et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. , 2003, Gastroenterology.
[169] F. Powrie,et al. Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.
[170] M. Neurath,et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. , 2003, The Journal of clinical investigation.
[171] A. Mowat,et al. Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.
[172] Subrata Ghosh,et al. Natalizumab for active Crohn's disease. , 2003, The New England journal of medicine.
[173] 武田 篤信. Cutting edge : Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment , 2003 .
[174] T. Hibi,et al. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement , 2002, American Journal of Gastroenterology.
[175] T. Mcclanahan,et al. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.
[176] S. Szabo,et al. The Transcription Factor T-bet Regulates Mucosal T Cell Activation in Experimental Colitis and Crohn's Disease , 2002, The Journal of experimental medicine.
[177] T. Macdonald,et al. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. , 2001, The Journal of clinical investigation.
[178] A. Sher,et al. Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation , 2001, Infection and Immunity.
[179] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[180] J. Casanova,et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.
[181] J Wagner,et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.
[182] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[183] M. Neurath,et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.
[184] S. Akira,et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.
[185] J M Ward,et al. Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.
[186] Samir A. Shah,et al. T Cell–mediated Pathology in Two Models of Experimental Colitis Depends Predominantly on the Interleukin 12/Signal Transducer and Activator of Transcription (Stat)-4 Pathway, but Is Not Conditional on Interferon γ Expression by T Cells , 1998, The Journal of experimental medicine.
[187] M. Neurath,et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.
[188] M. Leach,et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice , 1996, The Journal of experimental medicine.
[189] M. Neurath,et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.
[190] J. Mcghee,et al. Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. , 1995, Journal of immunology.
[191] S. Targan,et al. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. , 1995, Journal of immunology.
[192] R. Coffman,et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.
[193] R. Testi,et al. Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes , 1993, European journal of immunology.
[194] R. Coffman,et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.
[195] J. Watson,et al. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.